IRISanRaf

CATURANO, ALFREDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.120
NA - Nord America 2.513
SA - Sud America 1.262
EU - Europa 760
Continente sconosciuto - Info sul continente non disponibili 158
AF - Africa 73
OC - Oceania 15
Totale 8.901
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 2.635
US - Stati Uniti d'America 2.405
BR - Brasile 955
VN - Vietnam 539
IT - Italia 524
CN - Cina 313
BD - Bangladesh 287
AR - Argentina 126
HK - Hong Kong 114
EC - Ecuador 65
ID - Indonesia 60
NL - Olanda 53
MX - Messico 46
PK - Pakistan 43
CA - Canada 40
CO - Colombia 37
DE - Germania 31
GB - Regno Unito 30
IN - India 29
ZA - Sudafrica 28
PY - Paraguay 24
RU - Federazione Russa 21
CL - Cile 20
FR - Francia 16
IQ - Iraq 15
PL - Polonia 14
UA - Ucraina 13
IL - Israele 12
PE - Perù 12
VE - Venezuela 11
MA - Marocco 10
AU - Australia 9
IE - Irlanda 9
SA - Arabia Saudita 9
TR - Turchia 9
AT - Austria 7
EG - Egitto 7
TN - Tunisia 7
ES - Italia 6
NZ - Nuova Zelanda 6
UY - Uruguay 6
UZ - Uzbekistan 6
AM - Armenia 5
BO - Bolivia 5
NP - Nepal 5
AL - Albania 4
CR - Costa Rica 4
JO - Giordania 4
JP - Giappone 4
KZ - Kazakistan 4
MY - Malesia 4
NI - Nicaragua 4
TW - Taiwan 4
AO - Angola 3
AZ - Azerbaigian 3
HR - Croazia 3
KR - Corea 3
PT - Portogallo 3
RS - Serbia 3
AE - Emirati Arabi Uniti 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BG - Bulgaria 2
BW - Botswana 2
BY - Bielorussia 2
CH - Svizzera 2
DZ - Algeria 2
EE - Estonia 2
FI - Finlandia 2
KE - Kenya 2
MD - Moldavia 2
MU - Mauritius 2
PH - Filippine 2
PR - Porto Rico 2
QA - Qatar 2
SE - Svezia 2
SN - Senegal 2
TT - Trinidad e Tobago 2
BJ - Benin 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CD - Congo 1
CG - Congo 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GH - Ghana 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
IS - Islanda 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LY - Libia 1
Totale 8.734
Salva come PNG Salva come JPEG
Città #
Dallas 954
San Jose 424
Ashburn 284
Rome 278
Singapore 228
Ho Chi Minh City 193
Council Bluffs 154
Phoenix 140
Beijing 128
Hanoi 112
Hong Kong 111
São Paulo 83
Amsterdam 44
New York 40
Santa Clara 37
Los Angeles 35
Islamabad 30
Chicago 29
Naples 29
Rio de Janeiro 27
Mexico City 26
Buffalo 25
Haiphong 25
Milan 25
Quito 22
Guayaquil 21
Biên Hòa 16
Brasília 16
Munich 16
Manaus 15
Thái Bình 15
Da Nang 14
Hải Dương 14
Bogotá 13
Guarulhos 13
Johannesburg 13
Curitiba 12
Can Tho 11
Netanya 11
Porto Alegre 11
Asunción 10
Belo Horizonte 10
Bắc Ninh 10
Campinas 10
Dhaka 10
Jakarta 10
Ninh Bình 10
Orem 10
Thái Nguyên 10
Boardman 9
Brooklyn 9
Buenos Aires 9
Duque de Caxias 9
Frankfurt am Main 9
Montreal 9
Salvador 9
Bắc Giang 8
Caxias do Sul 8
Florence 8
Fortaleza 8
Goiânia 8
Maricá 8
Quảng Ngãi 8
Recife 8
Santiago 8
Santo André 8
Warsaw 8
Bauru 7
Dublin 7
Joinville 7
Lima 7
Petrópolis 7
São José 7
Toronto 7
Bandung 6
Bari 6
Cabo Frio 6
Cape Town 6
Chennai 6
Ha Long 6
Hortolândia 6
Palermo 6
Sorocaba 6
Sumaré 6
Suzano 6
Tashkent 6
Atlanta 5
Baghdad 5
Caruaru 5
Casablanca 5
Charlotte 5
City of London 5
Juiz de Fora 5
Lahore 5
Montevideo 5
Ribeirão Preto 5
San Francisco 5
São Bernardo do Campo 5
Vila Velha 5
Amman 4
Totale 4.125
Salva come PNG Salva come JPEG
Nome #
Nonalcoholic fatty liver disease and type 2 diabetes: pathophysiological mechanisms shared between the two faces of the same coin 304
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 250
Advances in Nanomedicine for Precision Insulin Delivery 248
The impact of incidental hepatocellular carcinoma in liver transplantation: A growing concern 239
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study 238
Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations 238
Advances in the Insulin–Heart Axis: Current Therapies and Future Directions 237
Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options 233
Diabetic Gastroparesis: Navigating Pathophysiology and Nutritional Interventions 233
Can metformin exert as an active drug on endothelial dysfunction in diabetic subjects? 225
Metabolic Dysfunction-Associated Steatotic Liver Disease in Klinefelter Syndrome: High Prevalence Uncovers an Unmet Need 223
Insulin–Heart Axis: Bridging Physiology to Insulin Resistance 218
SGLT2 Inhibitors and GLP-1 Receptor Agonists in PAD: A State-of-the-Art Review 199
Cardiovascular and Metabolic Disease: New Treatment and Future Directions—The 3rd Edition 178
Impact of Gliflozins on Right Heart Remodeling in Italian Patients with Type 2 Diabetes and Heart Failure: Results from the GLISCAR Real-World Study 167
Liver Involvement in Patients with Systemic Sclerosis: Role of Transient Elastography in the Assessment of Hepatic Fibrosis and Steatosis 144
Bridging ADHD and Metabolic Disorders: Insights into Shared Mechanisms and Clinical Implications 102
Risk Stratification For and Use of DOAC Therapies for Stroke Prevention in Patient with Atrial Fibrillation 96
Relationship between albuminuric CKD and diabetic retinopathy in a real-world setting of type 2 diabetes: Findings from No blind study 89
Alcohol Consumption and Liver Metabolism in the Era of MASLD: Integrating Nutritional and Pathophysiological Insights 80
Sex-difference of multifactorial intervention on cardiovascular and mortality risk in DKD: post-hoc analysis of a randomised clinical trial 79
Sarcopenic obesity and weight loss-induced muscle mass loss 77
Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications 73
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 72
Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease 71
Albuminuria-Lowering Effect of Dapagliflozin, Eplerenone, and Their Combination in Patients with Chronic Kidney Disease: A Randomized Crossover Clinical Trial 71
A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease 71
An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors 71
Assessment of Response and Safety of Bulevirtide Treatment in Patients with Chronic Delta Virus Infection: The ARISTOTLE Pilot Observational Study 71
ULTRASOUND TIPS IN THE LUNG CANCER DIAGNOSIS: A PILOT STUDY 62
Advancements in Cardiovascular and Antidiabetic Drug Therapy 61
Aspirin in a diabetic retinopathy setting: Insights from NO BLIND study 60
Long-term clinical outcomes of patients with drug-induced type 1 Brugada electrocardiographic pattern: A nationwide cohort registry study 59
Reply to Saeed et al. Comment on “Rinaldi et al. Assessment of Response and Safety of Bulevirtide Treatment in Patients with Chronic Delta Virus Infection: The ARISTOTLE Pilot Observational Study. Viruses 2025, 17, 251” 57
Cardiovascular and Metabolic Disease: New Treatment and Future Directions 2.0 57
Improvement of Global Longitudinal Strain and Myocardial Work in Type 2 Diabetes Patients on Sodium-Glucose Cotransporter 2 Inhibitors Therapy 56
Cardiovascular and Metabolic Disease: New Treatment and Future Directions 55
Atrial fibrillation and stroke. A review on the use of vitamin K antagonists and novel oral anticoagulants 55
Oral Anticoagulation for Atrial Fibrillation in Octogenarians Across the Renal Function Spectrum 54
Antioxidant and Antidiabetic Potential of the Antarctic Lichen Gondwania regalis Ethanolic Extract: Metabolomic Profile and In Vitro and In Silico Evaluation 53
NerveCheck master to screen patients with type 1 or type 2 diabetes for peripheral and cardiac autonomic neuropathy 53
Left bundle branch pacing and cardiac remodeling in HF patients with type 2 diabetes mellitus: epigenetic pathways and clinical outcomes 53
Electrophysiological Study Prognostic Value and Long-Term Outcome in Drug-Induced Type 1 Brugada Syndrome: The IBRYD Study 53
Commentary on Antithrombotic Effect of Protopanaxatriol Saponins from Panax notoginseng Using Zebrafish Model 52
Assessment of the Effectiveness of Ticagrelor Preloading in Mitigating Periprocedural Myocardial Injury Among Non-ST Elevation Myocardial Infarction Patients Opting for an Early Invasive Approach 52
The Dual Burden: Exploring Cardiovascular Complications in Chronic Kidney Disease 51
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options 51
Application and internal validation of lung ultrasound score in COVID-19 setting: The ECOVITA observational study 51
Insulin resistance and cancer: molecular links and clinical perspectives 51
Multidrug-Resistant Infections and Metabolic Syndrome: An Overlooked Bidirectional Relationship 50
Optimizing Body Composition During Weight Loss: The Role of Amino Acid Supplementation 50
Role of albuminuria in detecting cardio-renal risk and outcome in diabetic subjects 49
Remdesivir treatment and clinical outcome in non-severe hospitalized COVID-19 patients: a propensity score matching multicenter Italian hospital experience 49
Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes 49
Bivalirudin Use for Primary Percutaneous Coronary Intervention on Long-Term Mortality 49
Right ventricular electrocardiographic abnormalities among hospitalized COVID-19 patients: Simple marker of worst clinical outcome 48
Predictors of Plasma Levels of Direct Oral Anticoagulants Among Patients with Atrial Fibrillation in Need of Elective Cardiac Procedures 48
The Lipid-Lowering Efficacy of a Nutraceutical Combination Including Leucoselect Phytosome, Red Yeast Rice, Policosanol and Folic Acid in Dyslipidaemia Patients: Real-World Insights 48
Clinical performance of subcutaneous vs. transvenous implantable defibrillator in patients with ischemic cardiomyopathy: data from Monaldi Rhythm Registry 48
The Importance of Telemedicine during COVID-19 Pandemic: A Focus on Diabetic Retinopathy 47
Rethinking the Diabetes–Cardiovascular Disease Continuum: Toward Integrated Care 47
The prognostic role of interatrial block among COVID-19 patients hospitalized in medicine wards 47
Does a strict glycemic control during acute coronary syndrome play a cardioprotective effect? Pathophysiology and clinical evidence 47
Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study 47
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 47
Serum Lipids, Inflammation, and the Risk of Atrial Fibrillation: Pathophysiological Links and Clinical Evidence 46
Editorial on: Canagliflozin Mediates Mitophagy Through the AMPK/PINK1/PARKIN Pathway to Alleviate Isoprenaline-Induced Cardiac Remodeling 46
Optimizing Anticoagulation Management in Atrial Fibrillation: Beyond the Guidelines. How and for Whom? 46
Anti-Inflammatory and Anticancer Effects of Anticoagulant Therapy in Patients with Malignancy 46
Clinical Utilization and Performance of Bempedoic Acid in an Italian Real-World Setting: Insight from Campania Region 45
An Update on Betrixaban, the Challenging Anticoagulant Agent for Extended Venous Thromboembolism Prophylaxis 45
Metabolic Rewiring of Bacterial Pathogens in Response to Antibiotic Pressure—A Molecular Perspective 45
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes 45
HCC and molecular targeting therapies: Back to the future 45
The Intestinal Thread of Fate: How the Microbiota Shapes the Story of Liver Disease 45
Warfarin adherence and anticoagulation control in atrial fibrillation patients-a systematic review 45
Advances in Pharmacological Approaches for Managing Hypercholesterolemia: A Comprehensive Overview of Novel Treatments 43
Neurophysiological assessment of peripheral neuropathy through whole plantar nerve conduction in type 2 diabetes mellitus and healthy control subjects 43
Impact of sglt2 inhibitors on heart failure: From pathophysiology to clinical effects 43
Subcutaneous versus transvenous implantable cardioverter-defibrillator among drug-induced type-1 ECG pattern Brugada syndrome: a propensity score matching analysis from IBRYD study 43
Cardiorenal Impact of SGLT-2 Inhibitors: A Conceptual Revolution in The Management of Type 2 Diabetes, Heart Failure and Chronic Kidney Disease 42
Non-alcoholic fatty liver disease: From pathogenesis to clinical impact 41
When the dual-chamber pacing system is the optimal choice for Brugada patients in need of implantable cardiac defibrillator 41
HAND GRIP STRENGTH EVALUATION IN RHEUMATOLOGIC DISEASES 41
Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study 41
Oxidative Stress in Diabetic Cardiomyopathy: Molecular Mechanisms and Emerging Therapeutic Targets 41
Impact of Empagliflozin as add-on to Metformin vs Metformin continuation on MASLD Progression in Type 2 Diabetes: The IMAGIN Study 40
Effects of metformin in heart failure: From pathophysiological rationale to clinical evidence 39
Post-fracture thromboprophylaxis: is it time for a change? 39
Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy 39
Mechanisms of non-alcoholic fatty liver disease in the metabolic syndrome. A narrative review 38
Cardiovascular and Metabolic Disease: New Treatments and Future Directions 2.0 38
Comment on: Effect of Vitamin D supplementation in patients with liver cirrhosis having spontaneous bacterial peritonitis: a randomized controlled study 38
The impact of new onset diabetes on cardiovascular risks in orthotopic liver transplant recipients: findings from the COLT study 37
Cardiac Hypertrophy: From Pathophysiological Mechanisms to Heart Failure Development 37
The Significance of Statin-Associated Muscle Symptoms and Its Impact on Patient Adherence and Outcomes 37
New Advances in Cardiovascular Drugs: A Celebration of the 90th Birthday of Professor Akira Endo 36
Comment on: Warfarin adherence and anticoagulation control in atrial fibrillation patients-a systematic review 36
Oxidative Stress and Cardiovascular Complications in Type 2 Diabetes: From Pathophysiology to Lifestyle Modifications 36
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial 36
Totale 7.907
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.458
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.458
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20252.593 0 0 0 0 0 0 4 18 2 227 1.264 1.078
2025/20265.663 192 361 1.381 1.267 239 306 378 292 348 315 289 295
2026/2027645 65 411 169 0 0 0 0 0 0 0 0 0
Totale 8.901